These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31015570)

  • 1. The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143.
    Song J; Xie Q; Wang L; Lu Y; Liu P; Yang P; Chen R; Shao C; Qiao C; Wang Z; Yan J
    Sci Rep; 2019 Apr; 9(1):6354. PubMed ID: 31015570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TIR/BB-loop mimetic AS-1 prevents cardiac hypertrophy by inhibiting IL-1R-mediated MyD88-dependent signaling.
    Zhu Y; Li T; Song J; Liu C; Hu Y; Que L; Ha T; Kelley J; Chen Q; Li C; Li Y
    Basic Res Cardiol; 2011 Sep; 106(5):787-99. PubMed ID: 21533832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1/2, p38 and NF-κB pathways.
    Chen G; Pan SQ; Shen C; Pan SF; Zhang XM; He QY
    Acta Pharmacol Sin; 2014 Apr; 35(4):463-75. PubMed ID: 24608673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
    Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
    Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
    Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
    Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetramethylpyrazine inhibits angiotensin II-induced cardiomyocyte hypertrophy and tumor necrosis factor-α secretion through an NF-κB-dependent mechanism.
    Yu L; She T; Li M; Shi C; Han L; Cheng M
    Int J Mol Med; 2013 Sep; 32(3):717-22. PubMed ID: 23842595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
    Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
    J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
    Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
    Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT/NF-κB pathway.
    Tuo P; Zhao R; Li N; Yan S; Yang G; Wang C; Sun J; Sun H; Wang M
    Phytomedicine; 2024 Jun; 128():155464. PubMed ID: 38484625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL; Lv JB; Gao L
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Actions of AT
    Sparks MA; Rianto F; Diaz E; Revoori R; Hoang T; Bouknight L; Stegbauer J; Vivekanandan-Giri A; Ruiz P; Pennathur S; Abraham DM; Gurley SB; Crowley SD; Coffman TM
    Hypertension; 2021 Feb; 77(2):393-404. PubMed ID: 33390039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
    Ma E; Wu C; Chen J; Wo D; Ren DN; Yan H; Peng L; Zhu W
    Biomed Pharmacother; 2023 Sep; 165():115275. PubMed ID: 37541173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crucial Role of ROCK2-Mediated Phosphorylation and Upregulation of FHOD3 in the Pathogenesis of Angiotensin II-Induced Cardiac Hypertrophy.
    Zhou Q; Wei SS; Wang H; Wang Q; Li W; Li G; Hou JW; Chen XM; Chen J; Xu WP; Li YG; Wang YP
    Hypertension; 2017 Jun; 69(6):1070-1083. PubMed ID: 28438902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
    Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
    Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
    Zou XJ; Yang L; Yao SL
    Exp Biol Med (Maywood); 2008 Feb; 233(2):200-8. PubMed ID: 18222975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Mei ZL; Wang HB; Hu YH; Xiong L
    Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.